王紹明醫生 - 血液及血液腫瘤科
血液及血液腫瘤科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 血液及血液腫瘤科專科醫生香港中文大學內外全科醫學士 · 英國皇家內科醫學院院士 · 香港內科醫學院院士 · 1994 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
王紹明醫生是香港註冊的血液及血液腫瘤科專科醫生。
學歷
保險計劃
常見問題
王紹明醫生好嗎？
王紹明醫生是香港註冊的血液及血液腫瘤科專科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
王紹明醫生是做什麼的？
王紹明醫生是血液及血液腫瘤科醫生。
研究及論文
共 45 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group.Clinical hematology international · 2026
- Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.Blood advances · 2025
- Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group.Clinical hematology international · 2025
- Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review.International journal of molecular sciences · 2025
- Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan.Advances in therapy · 2025
- Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group.Clinical hematology international · 2025
- Safety, Efficacy, and Patient-Reported Outcomes From a Phase 2 Randomized Trial of Pozelimab and Cemdisiran Combination in Patients With Paroxysmal Nocturnal Hemoglobinuria.EJHaem · 2025
- Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation.Annals of hematology · 2025
- Real-World Use of carfilzomib-lenalidomide-dexamethasone (KRd) and carfilzomib-dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: A Prospective Multicenter Observational Study.Clinical lymphoma, myeloma & leukemia · 2025
- Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patterns.Proceedings of the National Academy of Sciences of the United States of America · 2024
- C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma.Blood advances · 2024
- Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus.International journal of molecular sciences · 2024
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
網上資料
以上連結按醫生姓名自動配對，未經醫生本人確認。香港同名者不少，請按連結自行核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明